South & Central America Rapid Test Kit Market Forecast to 2030 - Regional Analysis - by Type, Product, Technology, Application, and End User

Description

List of Tables

The South & Central America rapid test kit market was valued at US$ 926.12 million in 2022 and is expected to reach US$ 1,295.57 million by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030.

Increasing Preference for PCR Techniques Bolster South & Central America Rapid Test Kit Market

In recent years, molecular methods such as PCR have evolved as more effective diagnostic tools, as they aid in the precise diagnosis of a wide range of infectious diseases. Most of the popular molecular tests use reverse transcription polymerase chain reaction (RT-PCR). The technique provides reproducible results that are comparable between different laboratories and hence are accepted worldwide. The manufacturers are involved in new PCR developments.

For instance, GeneSoC is a recently developed system in which the PCR reaction solutions are reciprocally driven over numerous preheated zones and encapsulated on a chip within an extremely thin flow channel. GeneSoC is available for multiplex real-time PCR and is capable of concurrently detecting 3 fluorescence channels. It is regarded as an excellent alternative diagnostic technology for the detection of influenza A and B viruses, as it completes the real-time RT-PCR reaction in ~16 minutes. Further, the application of PCR technologies is also increasing in clinical microbiology, virology, parasitology, biotechnology, and allied fields due to the simple, rapid, and highly specific screening enabled by this tool. Thus, the growing preference for PCR as a diagnostic and clinical tool is expected to provide lucrative opportunities to the rapid test kits market during the forecast period.

South & Central America Rapid Test Kit Market Overview

According to the World Health Organization (WHO), Brazil is among the 20 countries with a high prominence rate of tuberculosis. Brazil accounted for 33% of total cases reported in 2020. In 2021, Brazil recorded 68,271 new TB cases, which corresponds to an incidence rate of 32 cases per 100,000 people. TB incidence is slowly increasing owing to an upward trend in Brazil. In Brazil, the Xpert MTB/RIF assay-a rapid molecular test for tuberculosis (RMT-TB)-is used to diagnose new cases of pulmonary and laryngeal tuberculosis in adults and adolescents.

During the COVID-19 pandemic in Brazil, the country's Health Ministry issued around a third of the 22.9 million RT-PCR test kits. The federal government provided 6.43 million real-time PCR assays for detecting SARS-CoV-2 in the states. Several players in Brazil are involved in the manufacturing of rapid test kits. Thus, the aforementioned factors are likely to contribute to the rapid test kits market growth.

South & Central America Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Rapid Test Kit Market Segmentation

The South & Central America rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the South & Central America rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the South & Central America rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the South & Central America rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the South & Central America rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the South & Central America rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the South & Central America rapid test kit market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, Guangzhou Wondfo Biotech Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the South & Central America rapid test kit market.

Product Code: BMIRE00030560

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Rapid Test Kits Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rising Prevalence of Genetic and Infectious Diseases
- 4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
- 4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
- 4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
- 4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis

5. Rapid Test Kits Market - South & Central America Market Analysis

5.1 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

6. South & Central America Rapid Test Kits Market Analysis - by Type

6.1 Overview
6.2 Rapid Antigen Testing
- 6.2.1 Overview
- 6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
- 6.3.1 Overview
- 6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
- 6.4.1 Overview
- 6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Rapid Test Kits Market Analysis - by Product

7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
- 7.2.1 Overview
- 7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
- 7.3.1 Overview
- 7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Rapid Test Kits Market Analysis - by Technology

8.1 Overview
8.2 Lateral Flow Assay
- 8.2.1 Overview
- 8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
- 8.3.1 Overview
- 8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
- 8.4.1 Overview
- 8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
- 8.5.1 Overview
- 8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
- 8.6.1 Overview
- 8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Rapid Test Kits Market Analysis - by Application

9.1 Overview
9.2 Blood Glucose Testing
- 9.2.1 Overview
- 9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
- 9.3.1 Overview
- 9.3.2 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
- 9.3.3 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
- 9.4.1 Overview
- 9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
- 9.5.1 Overview
- 9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Rapid Test Kits Market Analysis - by End User

10.1 Overview
10.2 Hospital and Clinics
- 10.2.1 Overview
- 10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
- 10.3.1 Overview
- 10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
- 10.4.1 Overview
- 10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Rapid Test Kits Market - Country Analysis

11.1 South & Central America
- 11.1.1 Overview
- 11.1.2 South & Central America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
  - 11.1.2.1 Brazil
    - 11.1.2.1.1 Overview
  - 11.1.2.2 Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.2.2.1 Brazil: Rapid Test Kits Market Breakdown, by Type
    - 11.1.2.2.2 Brazil: Rapid Test Kits Market Breakdown, by Product
    - 11.1.2.2.3 Brazil: Rapid Test Kits Market Breakdown, by Technology
    - 11.1.2.2.4 Brazil: Rapid Test Kits Market Breakdown, by Application
    - 11.1.2.2.4.1 Brazil: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
    - 11.1.2.2.5 Brazil: Rapid Test Kits Market Breakdown, by End User
  - 11.1.2.3 Argentina
    - 11.1.2.3.1 Overview
  - 11.1.2.4 Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.2.4.1 Argentina: Rapid Test Kits Market Breakdown, by Type
    - 11.1.2.4.2 Argentina: Rapid Test Kits Market Breakdown, by Product
    - 11.1.2.4.3 Argentina: Rapid Test Kits Market Breakdown, by Technology
    - 11.1.2.4.4 Argentina: Rapid Test Kits Market Breakdown, by Application
    - 11.1.2.4.4.1 Argentina: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
    - 11.1.2.4.5 Argentina: Rapid Test Kits Market Breakdown, by End User
  - 11.1.2.5 Rest of South & Central America
    - 11.1.2.5.1 Overview
  - 11.1.2.6 Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.2.6.1 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Type
    - 11.1.2.6.2 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Product
    - 11.1.2.6.3 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Technology
    - 11.1.2.6.4 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Application
    - 11.1.2.6.4.1 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
    - 11.1.2.6.5 Rest of South & Central America: Rapid Test Kits Market Breakdown, by End User

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Becton Dickinson and Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 ARKRAY Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Fujirebio Europe NV
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 bioMerieux SA
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Cepheid
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 QIAGEN NV
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Guangzhou Wondfo Biotech Co Ltd
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Abbott Laboratories
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Trinity Biotech Plc
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Bio-Rad Laboratories Inc
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 Hologic Inc
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 DiaSorin SpA
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 Premier Medical Corp Pvt Ltd
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments
13.16 Beckman Coulter Inc
- 13.16.1 Key Facts
- 13.16.2 Business Description
- 13.16.3 Products and Services
- 13.16.4 Financial Overview
- 13.16.5 SWOT Analysis
- 13.16.6 Key Developments

14. Appendix

14.1 About The Insight Partners